Compare VKTX & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VKTX | KD |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | United States | United States |
| Employees | N/A | 80000 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.8B |
| IPO Year | 2014 | 2021 |
| Metric | VKTX | KD |
|---|---|---|
| Price | $28.75 | $11.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $95.86 | $25.92 |
| AVG Volume (30 Days) | 1.9M | ★ 3.6M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $15,092,000,000.00 |
| Revenue This Year | N/A | $3.73 |
| Revenue Next Year | N/A | $0.08 |
| P/E Ratio | ★ N/A | $13.27 |
| Revenue Growth | N/A | ★ 0.23 |
| 52 Week Low | $22.96 | $10.10 |
| 52 Week High | $43.15 | $43.74 |
| Indicator | VKTX | KD |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 43.13 |
| Support Level | $25.77 | $11.11 |
| Resistance Level | $32.92 | $13.81 |
| Average True Range (ATR) | 1.29 | 0.52 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 30.67 | 31.77 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.